Health Services Administration: News and Research on Standard of Care

Supplemental indications in drug approval: Often no proof of added value, says researcher

Using health technology assessments from Germany and France, a study published in the BMJ by a team of Harvard researchers confirms a trend that has been apparent for some time: While in its first therapeutic indication about ...